Select for export Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmj-2023-078084 PubMed 38692686 Copy citation Copy BibTeX Unknown journal 2024-04-30 Metaxa AM, Clarke M. Europe PMC Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2024.1391689 PubMed 38741590 Copy citation Copy BibTeX Frontiers in Pharmacology 2024-04-28 Jan Thomann, Karolina E. Kolaczynska, Oliver V Stoeckmann, Deborah Rudin, Patrick Vizeli, Marius C. Hoener OpenAlex Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-024-02575-9 PubMed 38678087 Copy citation Copy BibTeX Molecular Psychiatry 2024-04-26 Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus OpenAlex Published psilocybin DepressionEating DisordersPharmacology Clinical Trial More
Select for export The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12888-024-05768-2 PubMed 38658877 Copy citation Copy BibTeX BMC Psychiatry 2024-04-24 Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen OpenAlex Published psilocybin Chronic PainBrain ImagingMechanism of Action Clinical Trial More
Select for export Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40337-024-01005-z PubMed 38659049 Copy citation Copy BibTeX Unknown journal 2024-04-23 Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M. Europe PMC Published psilocybin Eating DisordersHeadache / MigraineClinical Trial Clinical Trial More
Select for export MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.05.5.1 Copy citation Copy BibTeX Psychiatric News 2024-04-22 Terri D’Arrigo OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.04.19.590212 Copy citation Copy BibTeX bioRxiv 2024-04-21 Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E bioRxiv PREPRINT (not peer reviewed) psilocybin Receptor PharmacologyClinical TrialAnimal Study Clinical Trial More
Select for export Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acs.jmedchem.4c00082 PubMed 38648420 Copy citation Copy BibTeX Journal of Medicinal Chemistry 2024-04-21 Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits, Karla Frydenvang, Jesper L. Kristensen OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-04-18 Section for Affective Disorders; Northern Stockholm Psychiatry ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14728214.2024.2342951 PubMed 38606899 Copy citation Copy BibTeX Unknown journal 2024-04-17 Köhne S, Hillemacher T, Glahn A, Bach P. Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-58318-x PubMed 38632313 Copy citation Copy BibTeX Scientific Reports 2024-04-16 Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Psychedelic therapists, pharma collaborate on clinical trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/mhw.34009 Copy citation Copy BibTeX Mental Health Weekly 2024-04-12 Valerie A. Canady OpenAlex Published psilocybin Clinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Who will staff the psychedelic resurgence? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.56367/oag-042-10690 Copy citation Copy BibTeX Open Access Government 2024-04-08 Erika Dyck OpenAlex Published psilocybin DepressionAddictionClinical Trial Clinical Trial More
Select for export [Psychedelic psychiatry]. Abstract available at the source but not redistributed here. Read at source. Details PubMed 38572715 Copy citation Copy BibTeX Unknown journal 2024-04-03 López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/15563650.2024.2346612 PubMed 38753585 Copy citation Copy BibTeX Clinical Toxicology 2024-04-01 Rachael Wilkes, Darren M. Roberts, Paul Liknaitzky, Jonathan Brett OpenAlex Published psilocybin Clinical TrialObservational StudyHealthcare Workers Clinical Trial More
Select for export Current situation regarding psychedelics and magic mushroom in Korea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.1695 Copy citation Copy BibTeX European Psychiatry 2024-03-31 J. S. Seo OpenAlex Published psilocybinpsilocin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Microdosing psychedelics in the treatment of ADHD and comorbid disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.44 Copy citation Copy BibTeX European Psychiatry 2024-03-31 Kim P. C. Kuypers OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Clinical Trial More
Select for export Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamanetworkopen.2024.5960 PubMed 38598236 Copy citation Copy BibTeX Unknown journal 2024-03-31 Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/dddt.s443177 PubMed 38618282 Copy citation Copy BibTeX Drug Design Development and Therapy 2024-03-31 Sarah A. Norring, Michael G. Spigarelli OpenAlex Published psilocybin PharmacologyClinical TrialObservational Study Clinical Trial More
Select for export MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.04.4.1 Copy citation Copy BibTeX Psychiatric News 2024-03-25 Terri D’Arrigo OpenAlex Published psilocybin AnxietyPharmacologyClinical Trial Clinical Trial More
